What are the purposes for which Owkin and its partners could process patient data?

Owkin and its partners are using pseudonymised and/or de-identified data for their own research projects, especially involving AI technologies. Examples of their research projects include:

• developing diagnostic tools to improve how diseases are diagnosed or predicted.
• developing agentic tools to accelerate and de-risk clinical trials to help bring new drugs to the market more quickly.
• identifying new biomarkers or new targets that could lead to new treatments.

When conducting its research project, Owkin and its partners only used patient data which is strictly necessary and always processed it securely as described below.